Introduction: Beyond the Data The evolution from eminence-based to evidence-based care has come to define bedside emergency medicine, with rigorous skepticism and scholarly consideration accelerated by the power of global connectivity. Where anecdote and opinion once drove therapy, clinicians now ...
REBEL EM-ers: Salim, Jenny and I would like to announce the launch of a new REBEL EM project. Beginning in 2019, we’ll be adding a core content section to the website. This will include core content blog posts and a ...
Background Information: Sepsis is a complex syndrome frequently encountered in the ED. This infection-triggered, multifaceted disorder of life-threatening organ dysfunction is due to the body’s dysregulated response to pathologic and biochemical abnormalities.2-4 There has been significant debate regarding the use of ...
Friday, 2300 hours: A 24 year-old woman presents to your Emergency Department after a motor vehicle collision. She was the restrained driver of a car that collided head-on with another vehicle. She is complaining only of chest pain and appears ...
Background: Use of tranexamic acid (TXA), an antifibronlytic medication, has certainly become popular for numerous indications (i.e. trauma, uterine bleeding, epistaxis). Patients with hemoptysis, frequently come through EDs, and as an ED healthcare provider, I am unable to provide the definitive therapies ...
Background: Pulmonary embolism is the leading cause of death in pregnancy and the puerperium – accounting for nearly 20% of maternal deaths in the United States – making rapid and accurate diagnosis critically important for emergency physicians, OB/GYNs, and all ...
Background Information: Delirium is defined as an acute disorder of consciousness which can occur in up to 80% of mechanically ventilated ICU patients.1-5 This acute cognitive dysfunction is associated with prolonged hospital stay, increased mortality, longer periods of mechanical ventilation and long-term ...
Background: On October 24th, 2018, Roche, the maker of oseltamivir, announced that the US Food and Drug Administration (FDA) approved Xofluza (baloxavir marboxil) for the treatment of acute, uncomplicated influenza in people 12 years of age and older. Historically, there ...
Background: Cricoid pressure is dead, right? Many have made this claim including a brilliant argument against its use by John Hinds here. Despite the many eulogies, we continue to hear about cricoid pressure so it makes sense that we dive ...
In October 2016, I was exposed to the vast world of Free Open Access Medical Education and MedTwitter. I was astounded and inspired by the different educators who were trying to make learning easier. The Knowledge Translation (KT) gap was ...
1 email per week. No spam.
Sponsored
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.
